Your browser doesn't support javascript.
loading
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.
Rausch, Johanna; Dzama, Margarita M; Dolgikh, Nadezda; Stiller, Hanna L; Bohl, Stephan R; Lahrmann, Catharina; Kunz, Kerstin; Kessler, Linda; Echchannaoui, Hakim; Chen, Chun-Wei; Kindler, Thomas; Döhner, Konstanze; Burrows, Francis; Theobald, Matthias; Sasca, Daniel; Kühn, Michael W M.
  • Rausch J; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Dzama MM; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz.
  • Dolgikh N; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Stiller HL; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Bohl SR; Department of Medical Oncology, Dana- Farber Cancer Institute, Boston, MA.
  • Lahrmann C; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Kunz K; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Kessler L; Kura Oncology Inc., San Diego, CA 92130.
  • Echchannaoui H; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Chen CW; Department of Systems Biology, Beckman Research Institute City of Hope, Duarte, CA.
  • Kindler T; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Döhner K; Department of Internal Medicine III, Ulm University Hospital, Ulm.
  • Burrows F; Kura Oncology Inc., San Diego, CA 92130.
  • Theobald M; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Sasca D; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz.
  • Kühn MWM; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany; German Cancer Consortium (DKTK) partner site Frankfurt/Mainz and German Cancer Research Center (DKFZ) Heidelberg, Germany; University Cancer Center Mainz, Mainz. mickuehn@uni-main
Haematologica ; 108(10): 2837-2843, 2023 10 01.
Article en En | MEDLINE | ID: mdl-37102614
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromatina / Leucemia Mieloide Aguda Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cromatina / Leucemia Mieloide Aguda Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article